The Right Medicine
Oct 13, 2021
3 minutes
Kiera Butler
read that a cheap and plentiful drug called ivermectin had shown some promise in treating COVID-19, he was eager to study it. The University of Minnesota physician and infectious disease researcher had seen a few small but encouraging studies on the drug, which was most often used to treat parasites in both animals and people. Boulware set up the study early in 2021 with a methodology considered to be the gold standard: the randomized controlled trial, where one group of patients receives the drug, and the other gets a
You’re reading a preview, subscribe to read more.
Start your free 30 days